Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paclitaxel
MedTech
Bos Sci nets first US approval for drug-coated coronary balloon
Boston Scientific has received FDA approval for its Agent drug-coated balloon nearly a decade after it made its European debut.
Conor Hale
Mar 1, 2024 1:49pm
Novocure's electric fields fail phase 3 ovarian cancer trial
Aug 28, 2023 10:15am
FDA greenlights Urotronic's drug-coated balloon for BPH
Jul 17, 2023 10:28am
FDA rolls back warnings for paclitaxel-coated balloons, stents
Jul 13, 2023 1:15pm
ACC: Study finds no increased death risk with paclitaxel devices
May 16, 2021 5:30pm
FDA greenlights Boston Scientific's drug-coated Ranger balloon
Nov 3, 2020 11:22am